Fig. 2 | Scientific Reports

Fig. 2

From: Real-world study on the efficacy and safety of different treatment regimens in treatment-naïve CHB patients with high viral load

Fig. 2

Changes of HBV DNA in different antiviral regimens during the follow-up period. (A) the cumulative incidence of virological response (HBV DNA < 100 IU/ml) during the follow-up (B) change in HBV DNA decline in different time periods (C) change from baseline in HBV DNA levels at week 48. * P < 0.05 ** P < 0.01 *** P < 0.0001.

Back to article page